Brian C. DeSchuytner
Net Worth

Last updated:

What is Brian C. DeSchuytner net worth?

The estimated net worth of Mr. Brian C. DeSchuytner is at least $3,090,302 as of 3 Oct 2024. He owns shares worth $688,384 as insider, has earned $81,878 from insider trading and has received compensation worth at least $2,320,040 in Mersana Therapeutics, Inc..

What is the salary of Brian C. DeSchuytner?

Mr. Brian C. DeSchuytner salary is $580,010 per year as Senior Vice President & Chief Financial Officer in Mersana Therapeutics, Inc..

How old is Brian C. DeSchuytner?

Mr. Brian C. DeSchuytner is 47 years old, born in 1978.

What stocks does Brian C. DeSchuytner currently own?

As insider, Mr. Brian C. DeSchuytner owns shares in one company:

Company Title Shares Price per share Total value
Mersana Therapeutics, Inc. (MRSN) Senior Vice President & Chief Financial Officer 94,824 $7.26 $688,384

What does Mersana Therapeutics, Inc. do?

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

MRSN logo
MRSN
Mersana Therapeutics, Inc.
$7.26

Brian C. DeSchuytner insider trading

Mersana Therapeutics, Inc.

Mr. Brian C. DeSchuytner has made 4 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 5,598 units of MRSN stock worth $10,972 on 3 Oct 2024.

The largest trade he's ever made was exercising 50,000 units of MRSN stock on 1 Oct 2024. As of 3 Oct 2024 he still owns at least 94,824 units of MRSN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,598 $1.96 $10,972
Sale
Common Stock 8,089 $2 $16,178
Option
Common Stock 50,000 N/A N/A
Option
Restricted Stock Unit 50,000 N/A N/A
Sale
Common Stock 9,327 $2.71 $25,276
Option
Restricted Stock Unit 3,958 N/A N/A
Option
Restricted Stock Unit 6,250 N/A N/A
Option
Common Stock 6,250 N/A N/A
Option
Common Stock 3,958 N/A N/A
Option
Restricted Stock Unit 6,250 N/A N/A
Option
Common Stock 6,250 N/A N/A
Option
Restricted Stock Unit 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 5,131 $5.74 $29,452
Option
Restricted stock unit 3,958 N/A N/A
Option
Common Stock 6,250 N/A N/A
Option
Common Stock 3,958 N/A N/A
Option
Restricted stock unit 6,250 N/A N/A
Option
Restricted stock unit 6,250 N/A N/A
Option
Common Stock 6,250 N/A N/A
Option
Restricted Stock Units 6,250 N/A N/A
Option
Common Stock 10,208 N/A N/A
Option
Restricted Stock Units 3,958 N/A N/A
Option
Restricted Stock Units 3,959 $21.09 $83,495
Option
Common Stock 3,959 $21.09 $83,495

Mersana Therapeutics key executives

Mersana Therapeutics, Inc. executives and other stock owners filed with the SEC: